First In Human Study Of Sel24/Men1703, First In Class, Orally Available Dual Pim/Flt3 Kinase Inhibitor, In Patients With Acute Myeloid Leukemia

BLOOD(2019)

引用 2|浏览48
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要